Indeed, CD103 is induced in tumor-reactive T lymphocytes following TCR engagement with specific peptide-major histocompatibility complex (MHC)-class I complexes on cancer cells in a tumor microenvironment containing mature TGF-β. This evidence concerns the gene TGFB1 and neoplasm.